MLTX logo

MoonLake Immunotherapeutics Class A Ordinary Shares


MLTX: MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.


Show MLTX Financials

Consumer Interest
SEC Filings

Recent trades of MLTX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by MLTX's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of MLTX in WallStreetBets Daily Discussion


Recent insights relating to MLTX

CNBC Recommendations

Recent picks made for MLTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MLTX

Corporate Flights

Flights by private jets registered to MLTX